Trial intelligence / Profile preview

Calmoseptine vs Desitin for Diaper Dermatitis in Infants

NCT02716415Phase 4Completed

Sponsor
University of the Philippines
Start
Mar 2015
Primary completion
Mar 2018
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of Calmoseptine in diaper dermatitis, sponsored by University of the Philippines. Primary endpoint: Healing of Diaper Dermatitis at 6 days. Started Mar 2015; status: completed.

02

Drugs

Calmoseptine
03

Conditions

diaper dermatitis

Beyond the preview

Go deeper on NCT02716415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02716415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call